0001181431-14-034525.txt : 20141020 0001181431-14-034525.hdr.sgml : 20141020 20141020203059 ACCESSION NUMBER: 0001181431-14-034525 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141016 FILED AS OF DATE: 20141020 DATE AS OF CHANGE: 20141020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXACT SCIENCES CORP CENTRAL INDEX KEY: 0001124140 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 204782291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 441 CHARMANY DRIVE CITY: MADISON STATE: WI ZIP: 53719 BUSINESS PHONE: 608-284-5700 MAIL ADDRESS: STREET 1: 441 CHARMANY DRIVE CITY: MADISON STATE: WI ZIP: 53719 FORMER COMPANY: FORMER CONFORMED NAME: EXACT CORP DATE OF NAME CHANGE: 20000919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CRAWFORD SALLY CENTRAL INDEX KEY: 0001199735 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35092 FILM NUMBER: 141164776 MAIL ADDRESS: STREET 1: C/O HOLOGIC, INC. CITY: BEDFORD STATE: MA ZIP: 01730 4 1 rrd417745.xml OCTOBER 10B5-1 SALES X0306 4 2014-10-16 0 0001124140 EXACT SCIENCES CORP EXAS 0001199735 CRAWFORD SALLY C/O EXACT SCIENCES CORP. 441 CHARMANY DRIVE MADISON WI 53719 1 0 0 0 Common Stock 2014-10-16 4 M 0 5000 2.24 A 217341 D Common Stock 2014-10-16 4 M 0 15000 2.09 A 232341 D Common Stock 2014-10-16 4 M 0 7768 3.00 A 240109 D Common Stock 2014-10-16 4 S 0 27768 22.8418 D 212341 D Common Stock 2014-10-17 4 M 0 7232 3.00 A 219573 D Common Stock 2014-10-17 4 M 0 15000 0.71 A 234573 D Common Stock 2014-10-17 4 M 0 5536 3.43 A 240109 D Common Stock 2014-10-17 4 S 0 27768 23.6823 D 212341 D Common Stock 2014-10-20 4 M 0 2131 3.43 A 214472 D Common Stock 2014-10-20 4 M 0 15772 8.52 A 230244 D Common Stock 2014-10-20 4 M 0 5257 8.52 A 235501 D Common Stock 2014-10-20 4 M 0 4608 10.18 A 240109 D Common Stock 2014-10-20 4 S 0 27768 23.9323 D 212341 D Stock Option (right to buy) 2.24 2014-10-16 4 M 0 5000 0 D 2006-07-22 2015-07-22 Common Stock 15000 0 D Stock Option (right to buy) 2.09 2014-10-16 4 M 0 15000 0 D 2007-07-21 2016-07-21 Common Stock 15000 0 D Stock Option (right to buy) 3.00 2014-10-16 4 M 0 7768 0 D 2008-08-10 2017-08-10 Common Stock 15000 7232 D Stock Option (right to buy) 3.00 2014-10-17 4 M 0 7232 0 D 2008-08-10 2017-08-10 Common Stock 7232 0 D Stock Option (right to buy) 0.71 2014-10-17 4 M 0 15000 0 D 2009-07-18 2018-07-18 Common Stock 15000 0 D Stock Option (right to buy) 3.43 2014-10-17 4 M 0 5536 0 D 2011-07-16 2020-07-16 Common Stock 7667 2131 D Stock Option (right to buy 3.43 2014-10-20 4 M 0 2131 0 D 2011-07-16 2020-07-16 Common Stock 2131 0 D Stock Option (right to buy) 8.52 2014-10-20 4 M 0 15772 0 D 2014-07-28 2021-07-28 Common Stock 15772 0 D Stock Option (right to buy) 8.52 2014-10-20 4 M 0 5257 0 D 2012-07-28 2021-07-28 Common Stock 5257 0 D Stock Option (right to buy) 10.18 2014-10-20 4 M 0 4608 0 D 2013-07-26 2022-07-26 Common Stock 4608 0 D The exercise of these options and the subsequent sale of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted September 8, 2014. The sales of shares pursuant to this 10b5-1 trading plan and disclosed on this Form 4 reflect the execution of all shares subject to the 10b5-1 trading plan. As a result, the 10b5-1 trading plan has been terminated effective as of the filing of this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.65 to $23.11, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.50 to $24.02, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.72 to $24.05, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4. /s/ Sally Crawford by Mark R. Busch, attorney-in-fact 2014-10-20